Gabelli
- Average 12 Month ROI on "Buy" Recommendations
- 47.558%
- Based on
- 13 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Gabelli
- Iterum Therapeutics plc (NASDAQ: ITRM) was upgraded by analysts at Gabelli from a "sell" rating to a "hold" rating. They now have a $10.50 price target on the stock. (7/27/2021)
- Stanley Black & Decker, Inc. (NYSE: SWK) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. (6/17/2021)
- Iterum Therapeutics plc (NASDAQ: ITRM) was upgraded by analysts at Gabelli from a "sell" rating to a "hold" rating. (5/28/2021)
- Ferro Co. (NYSE: FOE) had its "sell" rating re-affirmed by analysts at Gabelli. (5/18/2021)
- nCino, Inc. (NASDAQ: NCNO) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. (5/14/2021)
